Global Dihydroartemisinin Market Insight 2020, Forecast to 2030
- Report Code : WOR2006636
- Published On: Aug, 2020
- Category : Chemicals & Materials
- Pages : 138
-
The Dihydroartemisinin market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Dihydroartemisinin is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Dihydroartemisinin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Dihydroartemisinin by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Dihydroartemisinin market are discussed.
The market is segmented by types:
Pharmaceutical Grade
Industrial Grade
It can be also divided by applications:
Malaria Treatment
Scientific Research
Others
And this report covers the historical situation, present status and the future prospects of the global Dihydroartemisinin market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Report Includes:
- xx data tables and xx additional tables
- An overview of global Dihydroartemisinin market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Dihydroartemisinin market
- Profiles of major players in the industry, including Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical..
Research Objectives
To study and analyze the global Dihydroartemisinin consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Dihydroartemisinin market by identifying its various subsegments.
Focuses on the key global Dihydroartemisinin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Dihydroartemisinin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dihydroartemisinin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
-
With tables and figures helping analyze worldwide Global Dihydroartemisinin market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Dihydroartemisinin Market Report 2020, Forecast to 2025
1 Scope of the Study1.1 Dihydroartemisinin Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Dihydroartemisinin Industry Overview2.1 Global Dihydroartemisinin Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Dihydroartemisinin Global Import Market Analysis
2.1.2 Dihydroartemisinin Global Export Market Analysis
2.1.3 Dihydroartemisinin Global Main Region Market Analysis2.2 Market Analysis by Type
2.2.1 Pharmaceutical Grade
2.2.2 Industrial Grade2.3 Market Analysis by Application
2.3.1 Malaria Treatment
2.3.2 Scientific Research
2.3.3 Others2.4 Global Dihydroartemisinin Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Dihydroartemisinin Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Dihydroartemisinin Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Dihydroartemisinin Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Dihydroartemisinin Manufacturer Market Share
2.4.5 Top 10 Dihydroartemisinin Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Dihydroartemisinin Market
2.4.7 Key Manufacturers Dihydroartemisinin Product Offered
2.4.8 Mergers & Acquisitions Planning2.5 Dihydroartemisinin Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Dihydroartemisinin Industry Impact
2.7.1 How the Covid-19 is Affecting the Dihydroartemisinin Industry
2.7.2 Dihydroartemisinin Business Impact Assessment - Covid-19
2.7.3 Market Trends and Dihydroartemisinin Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Dihydroartemisinin Manufacturing Cost Analysis3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Dihydroartemisinin Market Size Categorized by Regions4.1 Global Dihydroartemisinin Revenue, Sales and Market Share by Regions
4.1.1 Global Dihydroartemisinin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dihydroartemisinin Revenue and Market Share by Regions (2015-2020)4.2 Europe Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.3 APAC Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.4 North America Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.5 South America Dihydroartemisinin Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Dihydroartemisinin Sales and Growth Rate (2015-2020)
5 Europe Dihydroartemisinin Market Size Categorized by Countries5.1 Europe Dihydroartemisinin Sales, Revenue and Market Share by Countries
5.1.1 Europe Dihydroartemisinin Sales by Countries (2015-2020)
5.1.2 Europe Dihydroartemisinin Revenue by Countries (2015-2020)
5.1.3 Germany Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.1.4 UK Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.1.5 France Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.1.6 Russia Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.1.7 Italy Dihydroartemisinin Sales and Growth Rate (2015-2020)
5.1.8 Spain Dihydroartemisinin Sales and Growth Rate (2015-2020)5.2 Europe Dihydroartemisinin Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Dihydroartemisinin Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Dihydroartemisinin Sales Market Share by Type (2015-2020)
5.3.2 Europe Dihydroartemisinin Revenue and Revenue Share by Type (2015-2020)5.4 Europe Dihydroartemisinin Sales Market Share by Application (2015-2020)
6 Asia-Pacific Dihydroartemisinin Market Size Categorized by Countries6.1 Asia-Pacific Dihydroartemisinin Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Dihydroartemisinin Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Dihydroartemisinin Revenue by Countries (2015-2020)
6.1.3 China Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.1.4 Japan Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.1.5 Korea Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.1.6 India Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Dihydroartemisinin Sales and Growth Rate (2015-2020)
6.1.8 Australia Dihydroartemisinin Sales and Growth Rate (2015-2020)6.2 Asia-Pacific Dihydroartemisinin Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Dihydroartemisinin Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Dihydroartemisinin Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Dihydroartemisinin Revenue and Revenue Share by Type (2015-2020)6.4 Asia-Pacific Dihydroartemisinin Sales and Market Share by Application (2015-2020)
7 North America Dihydroartemisinin Market Size Categorized by Countries7.1 North America Dihydroartemisinin Sales, Revenue and Market Share by Countries
7.1.1 North America Dihydroartemisinin Sales by Countries (2015-2020)
7.1.2 North America Dihydroartemisinin Revenue by Countries (2015-2020)
7.1.3 United States Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.1.4 Canada Dihydroartemisinin Sales and Growth Rate (2015-2020)
7.1.5 Mexico Dihydroartemisinin Sales and Growth Rate (2015-2020)7.2 North America Dihydroartemisinin Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Dihydroartemisinin Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Dihydroartemisinin Sales Market Share by Type (2015-2020)
7.3.2 North America Dihydroartemisinin Revenue and Revenue Share by Type (2015-2020)7.4 North America Dihydroartemisinin Sales Market Share by Application (2015-2020)
8 South America Dihydroartemisinin Market Size Categorized by Countries8.1 South America Dihydroartemisinin Sales, Revenue and Market Share by Countries
8.1.1 South America Dihydroartemisinin Sales by Countries (2015-2020)
8.1.2 South America Dihydroartemisinin Revenue by Countries (2015-2020)
8.1.3 Brazil Dihydroartemisinin Sales and Growth Rate (2015-2020)8.2 South America Dihydroartemisinin Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Dihydroartemisinin Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Dihydroartemisinin Sales Market Share by Type (2015-2020)
8.3.2 South America Dihydroartemisinin Revenue and Revenue Share by Type (2015-2020)8.4 South America Dihydroartemisinin Sales Market Share by Application (2015-2020)
9 Middle East and Africa Dihydroartemisinin Market Size Categorized by Countries9.1 Middle East and Africa Dihydroartemisinin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dihydroartemisinin Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Dihydroartemisinin Revenue by Countries (2015-2020)
9.1.3 GCC Countries Dihydroartemisinin Sales and Growth Rate (2015-2020)
9.1.4 Turkey Dihydroartemisinin Sales and Growth Rate (2015-2020)
9.1.5 Egypt Dihydroartemisinin Sales and Growth Rate (2015-2020)
9.1.6 South Africa Dihydroartemisinin Sales and Growth Rate (2015-2020)9.2 Middle East and Africa Dihydroartemisinin Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Dihydroartemisinin Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Dihydroartemisinin Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Dihydroartemisinin Revenue and Revenue Share by Type (2015-2020)9.4 Middle East and Africa Dihydroartemisinin Sales Market Share by Application (2015-2020)
10 Global Dihydroartemisinin Market Segment by Type10.1 Global Dihydroartemisinin Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Dihydroartemisinin Sales and Market Share by Type (2015-2020)
10.1.2 Global Dihydroartemisinin Revenue and Market Share by Type (2015-2020)10.2 Pharmaceutical Grade Sales Growth Rate and Price
10.2.1 Global Pharmaceutical Grade Sales Growth Rate (2015-2020)
10.2.2 Global Pharmaceutical Grade Price (2015-2020)10.3 Industrial Grade Sales Growth Rate and Price
10.3.1 Global Industrial Grade Sales Growth Rate (2015-2020)
10.3.2 Global Industrial Grade Price (2015-2020)
11 Global Dihydroartemisinin Market Segment by Application11.1 Global DihydroartemisininSales Market Share by Application (2015-2020)
11.2 Malaria Treatment Sales Growth Rate (2015-2020)
11.3 Scientific Research Sales Growth Rate (2015-2020)
11.4 Others Sales Growth Rate (2015-2020)
12 Market Forecast for Dihydroartemisinin12.1 Global Dihydroartemisinin Revenue, Sales and Growth Rate (2020-2025)
12.2 Dihydroartemisinin Market Forecast by Regions (2020-2025)
12.2.1 Europe Dihydroartemisinin Market Forecast (2020-2025)
12.2.2 APAC Dihydroartemisinin Market Forecast (2020-2025)
12.2.3 North America Dihydroartemisinin Market Forecast (2020-2025)
12.2.4 South America Dihydroartemisinin Market Forecast (2020-2025)
12.2.5 Middle East & Africa Dihydroartemisinin Market Forecast (2020-2025)12.3 Dihydroartemisinin Market Forecast by Type (2020-2025)
12.3.1 Global Dihydroartemisinin Sales Forecast by Type (2020-2025)
12.3.2 Global Dihydroartemisinin Market Share Forecast by Type (2020-2025)12.4 Dihydroartemisinin Market Forecast by Application (2020-2025)
12.4.1 Global Dihydroartemisinin Sales Forecast by Application (2020-2025)
12.4.2 Global Dihydroartemisinin Market Share Forecast by Application (2020-2025)
13 Analysis of Dihydroartemisinin Industry Key Manufacturers13.1 Sanofi
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Sanofi Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Sanofi News13.2 KPC Pharmaceuticals
13.2.1 Company Details
13.2.2 Product Information
13.2.3 KPC Pharmaceuticals Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 KPC Pharmaceuticals News13.3 Guangxi Xiancaotang Pharmaceutical
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Guangxi Xiancaotang Pharmaceutical News13.4 Guilin Pharmaceutical
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Guilin Pharmaceutical Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Guilin Pharmaceutical News13.5 Kerui Nanhai Pharmaceutical
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Kerui Nanhai Pharmaceutical News13.6 Shanghai Natural Bio-engineering Co
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Shanghai Natural Bio-engineering Co News
13.7 Novanat Bioresource
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Novanat Bioresource Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Novanat Bioresource News
13.8 Botanical Extracts EPZ Ltd
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Botanical Extracts EPZ Ltd News
14 Research Findings and Conclusion
15 Appendix
-
The Global Dihydroartemisinin Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
A large number of Global Global Dihydroartemisinin players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.
According to the report, the Global Dihydroartemisinin Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
As the shift to value addition continues, companies in the Global Dihydroartemisinin Market face the dual challenge of improving interoperability to optimize performance and experience.
Companies in the Global Dihydroartemisinin Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Dihydroartemisinin Market's trajectory and future outlook.
